Animal studies in spinal cord injury: A systematic review of methylprednisolone

ATLA Alternatives to Laboratory Animals

Volumn 37, Issue 1, 2009, Pages 43-62

  Akhtar, Aysha Z ^a,b   Pippin, John J ^a   Sandusky, Chad B ^a  

^a PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE   (United States)

^b Oxford Centre for Animal Ethics   (United Kingdom)

Author keywords

Animal; Methylprednisolone; Spinal cord injury; Steroid

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFECT; EXPERIMENTAL ANIMAL; FOLLOW UP; METHODOLOGY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; RATING SCALE; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; SPINAL CORD INJURY; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALIA;

ANIMALS; CATS; DISEASE MODELS, ANIMAL; DOGS; HAPLORHINI; HUMANS; METHYLPREDNISOLONE; MICE; NEUROPROTECTIVE AGENTS; PREDICTIVE VALUE OF TESTS; RABBITS; RATS; RECOVERY OF FUNCTION; SHEEP; SPECIES SPECIFICITY; SPINAL CORD INJURIES;

EID: 64849097814     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290903700108     Document Type: Review

References (115)

1. Faden, I. & Stoica, B. (2007). Neuroprotection. Challenges and opportunities. Archives of Neurology 64, 794-800.
2. Benatar, M. (2007). Lost in translation: Treatment trials in the SOD1 mouse and in human ALS. Neurobiology of Disease 26, 1-13.
3. Pound, P., Ebrahim, S., Sandercock, P., Bracken, M.B. & Roberts, I. (2004). Where is the evidence that animal research benefits humans? British Medical Journal 328, 514-517.
4. Perel, P., Roberts, I., Sena, E., Wheble, P., Briscoe, C, Sandercock, P., Macleod, M., Mignini, L.E., Jayaram, P. & Khan, K.S. (2007). Comparison of treatment effects between animal experiments and clinical trials: systematic review. British Medical Journal 334, 197.
5. Gawrylewski, A. (2007). The trouble with animal models. Why did human trials fail? The Scientist 21, 44.
6. Bracken, M.B., Shepard, M.J., Holford, T.R., Leo- Summers, L., Aldrich, E.F., Fazl, M., Fehlings, M., Herr, D.L., Hitchon, P.W., Marshall, L.F., Nock- els, R.P., Pascale, V., Perot, P.L., Piepmeier, J., Sonntag, V.K.H., Wagner, F., Wilberger, J.E., Winn, H.R. & Young, W. (1997). Administration of methlyprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. JAMA 277, 1597-1604.
7. Bracken, M.B., Shepard, M.J., Collins, W.F., Holford, T.R., Young, W., Baskin, D.S., Eisenberg, H.M., Flamm, E., Leo-Summers, L. & Maroon, J. (1990). A randomized, controlled trial of methyl- prednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. The New England Journal of Medicine 322, 1405-1411.
8. Bledsoe, B.E., Wesley, A.K. & Salomone, J.P. (2004). High-dose steroids for acute spinal cord injury in emergency medical services. Prehospital Emergency Care 8, 313-316.
9. Cass, D.E., Dvorak, M.F., Fewer, D.H., Fox, R.J., Hugenholtz, H., Izukawa, D.M.S., Lexchin, J. & Tuli, S. (2003). Steroids in acute spinal cord injury. Canadian Journal of Emergency Medicine 5, 7-9. Available at: http://caep.ca/CMS/get-file.asp?id=531534FDA9BE41F5BF97BFFA0DlCD96 9&ext=.pdf&name=pg7.pdf (Accessed 13.10.08).
10. Hugenholtz, H. (2003). Methylprednisolone for acute spinal cord injury: not a standard of care. Canadian Medical Association Journal 168, 1145- 1146.
11. Bracken, M.B. (2001). Methylprednisolone and acute spinal cord injury. An update of the randomized evidence. Spine 26, S47-S54.
12. Wallman, P. & Mackway-Jones, K. (2000). Towards evidence based medicine: best BETs from the Manchester Royal Infirmary. Corticosteroids in acute spinal cord injury. Journal of Accident & Emergency Medicine 17, 215.
13. Coleman, W.P., Benzel, E., Cahill, D.W., Ducker, T., Geisler, F., Green, B., Gropper, M.R., Goffin, J., Madsen III, P.W., Maiman, D.J., Ondra, S.L., Rosner, M., Sasso, R.C., Trost, G.R. & Zeidman, S. (2000). A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. Journal of Spinal Disorders 13, 185-199.
14. Bayne, K. (2005). Potential for unintended consequences of environmental enrichment for laboratory animals and research results. Institute of Laboratory Animal Resources Journal 46, 129 - 139.
15. Horn, J., de Haan, R.J., Vermeulen, M., Luiten, P.G.M. &Limburg, M. (2001). Nimodipine in animal model experiments of focal cerebral ischemia. A systematic review. Stroke 32, 2433-2438.
16. Lee, D.S., Quang, T.N., Lapointe, N., Austin, P.C., Ohlsson, A., Tu, J.V., Stewart, D.J. & Rouleau, J.L. (2003). Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure. Journal of Cardiac Failure 9, 368-374.
17. Iizuka, H., Iwasaki, Y., Yamamoto, T. & Kadoya, S. (1986). Morphometric assessment of drug effects in experimental spinal cord injury. Journal of Neurosurgery 65, 92-98.
18. Ross, I.B., Tator, C.H. & Theriault, E. (1993). Effect of nimodipine or methylprednisolone on recovery from acute experimental spinal cord injury in rats. Surgical Neurology 40, 461-470.
19. van de Meent, H., Hamers, F.P.T., Lankhorst, A.J., Joosten, E.A.J. & Gispen, W.H. (1997). Beneficial effects of the melanocortin [alpha]-melanocyte- stim- ulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury. Neurosurgery 40, 122-131.
20. Lankhorst, A.J., ter Laak, M.P., Hammers, F.P.T. & Gispen, W.H. (2000). Combined treatment with alpha MSH and methylprednisolone fails to improve functional recovery after spinal injury in the rat. Brain Research 859, 334-340.
21. Chikawa, T., Ikata, T., Katoh, S., Hamada, Y., Kogure, K. & Fukuzawa, K. (2001). Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes. Journal of Neurotrauma 18, 93-103.
22. Taoka, Y., Okajima, K, Uchiba, M. & Johno, M. (2001). Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-alpha production. Journal of Neurotrauma 18, 533-543.
23. Sharma, A., Tiwari, R., Badhe, P. & Sharma, G. (2004). Comparison of methylprednisolone with dexamethasone in treatment of acute spinal injury in rats. Indian Journal of Experimental Biology 42, 476-480.
24. Jiang, S., Khan, M.I., Middlemiss, P.J., Lu, Y, Werstiuk, E.S., Crocker, C.E., Ciccarelli, R., Caiagli, F. & Rathbone, M.P. (2004). AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats. International Journal of Immunopathology & Pharmacology 17, 353-366.
25. Kalayci, M., Coskun, O., Ca gavi, F., Kanter, M., Armutcu, F., Gill, S. & Acikgoz, B. (2005). Neuroprotective effects of ebselen on experimental spinal cord injury in rats. Neurochemical Research 30, 403-410.
26. Weaver, L.C., Gris, D., Saville, L.R., Oatway, M.A., Chen, Y., Marsh, D.R., Hamilton, E.F. & Dekaban, G.A. (2005). Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. Journal of Neurotrauma 22, 1375-1387.
27. Gill, S., Celik, S.E., Kalayci, M., Tasyurekli, M., Cokar, N. & Bilge, T. (2005). Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats. Surgical Neurology 64, 355-361.
28. Boran, B.O., Colak, A. & Kutlay, M. (2005). Erythropoietin enhances neurological recovery after experimental spinal cord injury. Restorative Neurology& Neuroscience 23, 341-345.
29. Kaptanoglu, E., Caner, H., Solaroglu, I. & Kiline, K. (2005). Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury. Journal of Neurosurgery. Spine 3, 53-56.
30. Kanter, M., Coskun, O., Kalayci, M., Buyukbas, S. & Cagavi, F. (2006). Neuroprotective effects of Nigella sativa on experimental spinal cord injury in rats. Human & Experimental Toxicology 25, 127-133.
31. Yucel, N., Cayli, S.R., Ates, O., Karadag, N., Firat, S. & Turkoz, Y. (2006). Evaluation of the neuroprotective effects of citoline after experimental spinal cord injury: Improved behavioral and neu- roanatomical recovery. Neurochemical Research 31, 767-775.
32. Ates, O., Cayli, S., Altinoz, E., Gurses, I., Yucel, N. Kocak, A., Yologlu, S. & Turkoz, Y. (2006). Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury. Acta Pharmacologica Sinica 27, 1317-1325.
33. Gok, B., Okutan, O., Beskonakli, E. & Kiline, K. (2007). Effects of magnesium sulphate following spinal cord injury in rats. Chinese Journal of Physiology 50, 93-97.
34. Okutan, O., Solaroglu, I., Beskonakli, E. & Taskin, Y. (2007). Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats. Journal of Clinical Neuroscience 14, 364-368.
35. O'Callaghan, W.J. & Speakman, T.J. (1963). Axon regeneration in the rat spinal cord. Surgical Forum 14, 410-411.
36. Holtz, A., Nystrom, B. & Gerdin, B. (1990). Effect of methylprednisolone on motor function and spinal cord blood flow after spinal cord compression in rats. Acta Neurological Scandinavica 82, 68-73.
37. Benzel, E.C., Hoffpauir, G.M., Thomas, M.M., Beal, J.A., Lancon, J.A. & Kesterson, L. (1990). Dose-dependent effects of naloxone and methylprednisolone in the ventral compression model of spinal cord injury. Journal of Spinal Disorders 3, 339-344.
38. Holtz, A. & Gerdin, B. (1991). Blocking weight- induced spinal cord injury in rats: therapeutic effect of the 21-aminosteroid U74006F. Journal of Neurotrauma 8, 239-245.
39. Iwai, A., Monafo, W.W. & Eliasson, S.G. (1993). Methylprednisolone treatment of experimental spinal cord injury. Paraplegia 31, 417-429.
40. Behrmann, D.L., Bresnahan, J.C. & Beattie, M.S. (1994). Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Experimental Neurology 126, 61-75.
41. Farooque, M., Olsson, Y. & Holtz, A. (1994). Effect of the 21-aminosteroid U74006F and methylprednisolone on motor function recovery and oedema after spinal cord compression in rats. Acta Neur- ologica Scandinavica 89, 36-41.
42. Perez-Espejo, M.A., Haghighi, S.S., Adelstein, E.H. & Madsen, R. (1996). The effects of taxol, methylprednisolone and 4-aminopyridine in compressive spinal cord injury: a qualitative experimental study. Surgical Neurology 46, 350-357.
43. Haghighi, S.S., Clapper, A., Johnson, G.C., Stevens, A. & Prapaisilp, A. (1998). Effect of 4-aminopyridine and single-dose methylprednisolone on functional recovery after a chronic spinal cord injury. Spinal Cord 36, 6-12.
44. Haghighi, S.S., Agrawal, S.K., Surdell, D., Plam- beck, R., Agrawal, S., Johnson, G.C. & Walker, A. (2000). Effects of methylprednisolone and MK-801 on functional recovery after experimental chronic spinal cord injury. Spinal Cord 38, 733-740.
45. Hara, M., Takayasu, M., Watanabe, K., Noda, A., Takagi, T., Suzuki, Y. & Yoshida, J. (2000). Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats. Journal of Neurosurgery 93, Suppl. 1, 94-101.
46. Legos, J.J., Gritman, K.R., Tuma, R.F. & Young, W.F. (2001). Coadministration of methylprednisolone with hypertonic saline solution improves overall neurological function and survival rates in a chronic model of spinal cord injury. Neurosurgery 49, 1427-1433.
47. Nash, H.H., Borke, R.C. & Anders, J.J. (2002). Ensheathing cells and methylprednisolone promote axonal regeneration and functional recovery in the lesioned adult rat spinal cord. Journal of Neuroscience 22, 7111-7120.
48. Rabchevsky, A.G., Fugaccia, I., Sullivan, P.G., Blades, D.A. & Scheff, S.W. (2002). Efficacy of methylprednisolone therapy for the injured rat spinal cord. Journal of Neuroscience Research 68, 7-18.
49. Lixin, L.I., Qiwu, X.U., Youzhang, W.U. Weixing, H.U., Peiyuan, G.U. & Zhen, F.U. (2003). Combined therapy of methylprednisolone and brain- derived neurotrophic factor promotes axonal regeneration and functional recovery after spinal cord injury in rats. Chinese Medical Journal 116, 414-418.
50. Yu, Y., Matsuyama, Y., Nakashima, S., Yanase, M., Kiuchi, K. & Ishiguro, N. (2004). Effects of MPSS and a potent iNOS inhibitor on traumatic spinal cord injury. NeuroReport 15, 2103-2107.
51. Kim, D.H. & Jahng, T-A. (2004). Continuous brain-derived neurotrophic factor (BDNF) infusion after methylprednisolone treatment in severe spinal cord injury. Journal of Korean Medical Science 19, 113-122.
52. Gorio, A., Madaschi, L., Di Stefano, B., Carelli, S., Di Giulio, A.M., Biasi, S., Coleman, T., Cerami, A. & Brines, M. (2005). Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proceedings of the National Academy of Sciences of the USA 102, 16,379-16,384.
53. Lee. B.H., Lee, K.H., Yoon, D.H., Kim, U.J., Hwang, Y.S., Park, S.K., Choi, J.U. & Park, Y.G. (2005). Effects of methylprednisolone on the neural conduction of the motor evoked potentials in spinal cord injured rats. Journal of Korean Medical Science 20, 132-138.
54. Lopez-Vales, R., Guillermo, G-A., Fores, J., Udina, E., Gold, B.G., Navarro, X. & Verdu, E. (2005). FK506 reduces tissue damage and prevents functional deficit after spinal cord injury in the rat. Journal of Neuroscience Research 81, 827-836.
55. Cetin, A., Nas, K., Buyukbayram, H., Ceviz, A. & Olmez, G. (2006). The effects of systematically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats. European Spine Journal 15, 1539-1544.
56. Zileli, M., Ovul, I. & Dalbasti, T. (1988). Effects of methylprednisolone, dimethyl sulphoxide and naloxone in experimental spinal cord injuries in rats. Neurological Research 10, 232-235.
57. Cayli, S.R., Kocak, A., Yilmaz, U., Tekiner, A., Erbil, M., Ozturk, C., Batcioglu, K. & Yologlu, S. (2004). Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. European Spine Journal 13, 724-732.
58. Cayli, S.R., Ates, O., Karadag, N., Altinoz, E., Yucel, N., Yologlu, S., Kocak, A. & Cakir, CO. (2006). Neuroprotective effect of etomidate on functional recovery in experimental spinal cord injury. International Journal of Developmental Neuroscience 24, 233-239.
59. Takami, T., Oudega, M., Bethea, J.R., Wood, P.M., Kleitman, N. & Bunge, M.B. (2002). Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. Journal of Neurotrauma 19, 653-666.
60. Guizar-Sahagun, G., Grijalva, I., Salgado-Ceballos, H., Espitia, A., Orozco, S., Ibarra, A., Martinez, A., Franco-Bourland, R.E. & Madrazo, I. (2004). Spontaneous and induced aberrant sprouting at the site of injury is irrelevant to motor function outcome in rats with spinal cord injury. Brain Research 1013, 143-151.
61. Mu, X., Azbill, R.D. & Springer, J.E. (2000). Ril- uzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury. Journal of Neurotrauma 17, 773-780.
62. Ji, B., Li, M., Budel, S., Pepinsky, B., Walus, L., Engber, T.M., Strittmatter, S.M. & Relton, J.K. (2005). Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. European Journal of Neuroscience 22, 587-594.
63. Guizar-Sahagun, G., Ibarra, A., Espitia, A., Martinez, A., Madrazo, I. & Franco-Bourland, R.E. (2005). Glutathione monoethyl ester improves functional recovery, enhances neuron survival, and stabilizes spinal cord blood flow after spinal cord injury in rats. Neuroscience 130, 639-649.
64. Wells, J.E.A., Hurlbert, R.J., Fehlings, M.G. & Yong, V.W. (2003). Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126, 1628-1637.
65. Sheng, H., Spasojevic, I., Warner, D.S. & Batinic- Haberle, I. (2004). Mouse spinal cord compression injury is ameliorated by intrathecal cationic manganese (III) porphyrin catalytic antioxidant therapy. Neuroscience Letters 366, 220-225.
66. Anghelescu, N., Petrescu, A. & Alexandrescu, I. (1995). Therapy study on the experimental injury of spinal cord IV. High doses of methylprednisolone. Romanian Journal of Neurology& Psychiatry 33, 241-249.
67. 2A agonism and methylprednisolone in attenuating neuronal damage and improving functional outcome after experimental traumatic spinal cord injury in rabbits. Journal of Neurosurgery. Spine 4, 64-70.
68. Means, E.D., Anderson, D.K., Waters, B.S. & Kalaf, L. (1981). Effect of methylprednisolone in compression trauma to the feline spinal cord. Journal of Neurosurgery 55, 200-208.
69. Demopoulos, H.B., Flamm, E.S., Seligman, M.L., Pietronigro, D.D. & De Crescito, V. (1982). Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury. Canadian Journal of Physiology& Pharmacology 60, 1415- 1424.
70. Faden, A.I., Jacobs, T.P., Patrick, D.H. & Smith, M.T. (1984). Megadose corticosteroid therapy following experimental traumatic spinal injury. Journal of Neurosurgery 60, 712-717.
71. Anderson, D.K., Saunders, R.D., Demediuk, P., Dugan, L.L., Braughler, M., Hall, E.D., Means, E.D. & Horrocks, L.A. (1985). Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium. Central Nervous System Trauma 2, 257-267.
72. Braughler, J.M., Hall, E.D., Means, E.D., Waters, T.R. & Anderson, D.K. (1987). Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. Journal of Neurosurgery 67, 102-105.
73. Young, W., De Crescito, V., Flamm, E.S., Blight, A.R. & Gruner, J.A. (1988). Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone. Clinical Neurosurgery 34, 675-697.
74. Ducker, T.B. & Hamit, H.F. (1969). Experimental treatments of acute spinal cord injury. Journal of Neurosurgery 30, 693-697.
75. Coates, J.R., Sorjonen, D.C., Simpson, S.T., Cox, N.R., Wright, J.C., Hudson, J.A., Finn-Bodner, S.T. & Brown, S.A. (1995). Clinicopathologic effects of a 21-aminosteroid compound (U74389G) and high- dose methylprednisolone on spinal cord function after simulated spinal cord trauma. Veterinary Surgery 24, 128-139.
76. Yang, J., Jeong, S., Seo, K. & Nam, T. (2003). Effects of corticosteroid and electroacupuncture on experimental spinal cord injury in dogs. Journal of Veterinary Science 4, 97-101.
77. Yeo, J.D., Payne, W., Hinwood, B. & Kidman, A.D. (1975). The experimental contusion injury of the spinal cord in sheep. Paraplegia 12, 275-296.
78. Green, B.A., Kahn, T. & Klose, K.J. (1980). A comparative study of steroid therapy in acute experimental spinal cord injury. Surgical Neurology 13, 91-97.
79. Young, W. (2002). Spinal cord contusion models. Progress in Brain Research 137, 231-255.
80. Werner, C, Mollenberg, O., Kochs, E. & Schulte am Esch, J. (1995). Sevoflurane improves neurological outcome after incomplete cerebral ischaemia in rats. British Journal of Anaesthesia 75, 756-760.
81. Lopez, S., Privat, A., Bernard, N., Ohanna, F., Vergnes, C. & Capdevila, X. (2004). Intrathecal bupivacaine protects against extension of lesions in an acute photochemical spinal cord injury model. Canadian Journal of Anaesthesia 51, 364-372.
82. Augustsson, H., Lindberg, L., Hoglund, A.U. & Dahlborn, K. (2002). Human-animal interactions and animal welfare in conventionally and pen- housed rats. Laboratory Animals 36, 271-281.
83. Balcombe, J.P., Barnard, N.D. & Sandusky, C. (2004). Laboratory routines cause animal stress. Contemporary Topics in Laboratory Animal Sciences 43, 42-51.
84. Vallee, M., Mayo, W., Maccari, S., Le Moal, M. & Simon, H. (1996). Long-term effects of prenatal stress and handling on metabolic parameters: relationship to corticosterone secretion response. Brain Research 712, 287-292.
85. Benefiel, A.C., Dong, W.K. & Greenough, W.T. (2005). Mandatory "enriched" housing of laboratory animals: The need for evidence-based evaluation. Institute of Laboratory Animal Resources Journal 46, 95-105.
86. Krohn, T.C., Hansen, A.K. & Dragsted, N. (2003). The impact of cage ventilation on rats housed in IVC systems. Laboratory Animals 37, 85-93.
87. Dobrossy, M.D. & Dunnett, S.B. (2004). Environmental enrichment affects striatal graft morphology and functional recovery. European Journal of Neuroscience 19, 159-168.
88. Engesser-Cesar, C., Anderson, A.J., Basso, D.M., Edgerton, V.R. & Cotman, C.W. (2005). Voluntary wheel running improves recovery from a moderate spinal cord injury. Journal of Neurotrauma 22, 157-171.
89. Lankhorst, A.J., ter Laak, M.P., van Laar, T.J., van Meeteren, N.L.U., de Groot, J.C.M.J., Schrama, L.H., Hamers, F.P. & Gisoen, W.H. (2001). Effects of enriched housing on functional recovery after spinal cord contusive injury in the adult rat. Journal of Neurotrauma 18, 203-215.
90. Van Loo, P.L.P., Van der Meer, E., Kruitwagen, C.L.J.J., Koolhaas, J.M., Van Zutphen, L.F.M. & Baumans, V. (2004). Long-term effects of husbandry procedures on stress-related parameters in male mice of two strains. Laboratory Animals 38, 169-177.
91. Rabchevsky, A.G. & Smith, G.M. (2001). Therapeutic interventions following mammalian spinal cord injury. Archives of Neurology 58, 721-726.
92. Rosenzweig, E.S. & McDonald, J.W. (2004). Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair. Current Opinion in Neurology 17, 121-131.
93. Stoke, B.T. & Jakeman, L.B. (2002). Experimental modeling of human spinal cord injury: a model that crosses the species barrier and mimics the spectrum of human cytopathology. Spinal Cord 40, 101-109.
94. Kwon, B.K., Oxland, T.R. & Tetzlaff, W. (2002). Animal models used in spinal cord regeneration research. Spine 27, 1504-1510.
95. Chesler, E.J., Wilson, S.G., Lariviere, W.R., Rodriguez-Zas, S.L. & Mogil, J.S. (2002). Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive. Neuroscience& Biobehavioral Reviews 26, 907-923.
96. Crabbe, J.C., Wahlsten, D. & Dudek, B.C. (1999). Genetics of mouse behavior: interactions with laboratory environment. Science 284, 1670-1672.
97. Guth, L., Zhang, Z. & Steward, O. (1999). The unique histopathological responses of the injured spinal cord. Implications for neuroprotective therapy. Annals of the New York Academy of Sciences 890, 366-384.
98. Inman, D.M. & Steward, O. (2003). Physical size does not determine the unique histopathological response seen in the injured mouse spinal cord. Journal of Neurotrauma 20, 33-42.
99. De La Torre, J.C. (1984). Spinal cord injury models. Progress in Neurobiology 22, 289-344.
100. Committee on Spinal Cord Injury (2005). Tools for assessing spinal cord injury and repair. In Spinal Cord Injury: Progress, Promise and Priorities, (ed. C.T. Liverman, B.M. Altevogt, J.E. Joy & R.T. Johnson), pp. 64-94. Washington, DC, USA: The National Academies Press. Available at: http://www.iom.edu/CMS/3775/14986/26196.aspx (Accessed 14.01.09).
101. Popovich, P.G., Wei, P. & Stokes, B.T. (1997). Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. The Journal of Comparative Neurology 377, 443-464.
102. Sroga, J.M., Jones, T.B., Kigerl, K.A., McGaughy, V.M. & Popovich, P.G. (2003). Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. The Journal of Comparative Neurology 462, 223-240.
103. Akhtar, A., Pippin, J. & Sandusky. C. (2008). Animal models in spinal cord injury: A review. Reviews in the Neurosciences 19, 47-60.
104. Kakulas, B.A. (1999). The applied neuropathology of human spinal cord injury. Spinal Cord 37, 79-88.
105. Tom, V.J., Steinmetz, M.P., Miller, J.H., Doller, CM. & Silver, J. (2004). Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, and an in vitro model of the glial scar after spinal cord injury. The Journal of Neuroscience 24, 6531-6539.
106. Fayaz, I. & Tator, C.H. (2000). Modeling axonal injury in vitro: injury and regeneration following acute neuritic trauma. Journal of Neuroscience Methods 102, 69-79.
107. Woolfe, F., Waxman, S.G. & Hains, B.C. (2007). In silico modeling of axonal reconnection within a discrete fiber tract after spinal cord injury. Journal of Neurotrauma 24, 421-432.
108. Lucas, J.H., Gross, G.W. Emery, D.G. & Gardner, C.R. (1985). Neuronal survival or death after dendrite transection close to the perikaryon: correlation with electrophysiologic, morphologic, and ultrastructural changes. C/VS Trauma 2, 231-255.
109. Raghupathi, R., Grants, I., Rosenberg, L.J., Mcintosh, T.K. & Lucas, J.H. (1998). Increased jun immunoreactivity in an in vitro model of mammalian spinal neuron physical injury. Journal of Neurotrauma 15, 555-561.
110. Krassioukov, A.V., Ackery, A., Schwartz, G., Adam- chik, Y., Liu, Y. & Fehlings, M.G. (2002). An in vitro model of neurotrauma in organotype spinal cord cultures from adult mice. Brain Research Protocols 10, 60-68.
111. Ellis, E.F., McKinney, J.S., Willoughby, K.A., Liang, S. & Povlishock, J.T. (1995). A new model for rapid stretch-induced injury of cells in culture: characterization of the model using astrocytes. Journal of Neurotrauma 12, 325-339.
112. Regan, R.F. & Panter, S.S. (1995). Traumatic neuronal injury in cortical cell culture is attenuated by 21-aminosteroids. Brain Research 682, 144- 150.
113. Li, R., Thode, S., Zhou, J., Richard, N., Pardinas, J., Rao, M.S. & Sah, D.W. (2000). Motoneuron differentiation of immortalized human spinal cord cell lines. Journal of Neuroscience Research 59, 342-352.
114. Raymon, H.K., Thode, S., Zhou, J., Friedman, G.C., Pardinas, J.R., Barrere, C, Johnson, R.M. & Sah, D.W. (1999). Immortalized human dorsal root ganglion cells differentiate into neurons with nociceptive properties. The Journal of Neuroscience 19, 5420-5428.
115. The Miami Project to Cure Paralysis. Available at: http://www. miamiproject.miami.edu/x350.xml (Accessed 29.02.08).